2017
DOI: 10.1016/j.tacc.2017.09.054
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of SuperNO 2 VA™ mask technology in a clinical setting: A pilot study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 13 publications
0
7
0
1
Order By: Relevance
“…Studies that demonstrate the use of the SuperNO 2 VA TM in the operating room during the process of securing a difficult airway, or attaching the SuperNO 2 VA TM to a hyperinflation bag for transport to the PACU have already been reported. 21 The observations of this case series are encouraging, and suggest that a pressurized nasal ventilation mask may be a preferable alternative to improve oxygenation and ventilation in high-risk patients during deep sedation. These observations are promising, yet randomized clinical trials are…”
Section: Discussionmentioning
confidence: 64%
“…Studies that demonstrate the use of the SuperNO 2 VA TM in the operating room during the process of securing a difficult airway, or attaching the SuperNO 2 VA TM to a hyperinflation bag for transport to the PACU have already been reported. 21 The observations of this case series are encouraging, and suggest that a pressurized nasal ventilation mask may be a preferable alternative to improve oxygenation and ventilation in high-risk patients during deep sedation. These observations are promising, yet randomized clinical trials are…”
Section: Discussionmentioning
confidence: 64%
“…In all but one patient, anesthesiologists were able to use the SuperNO 2 VA™ to provide adequate ventilation during induction and laryngoscopy. 6 The Su-perNO 2 VA™ provides non-invasive, continuous ventilation via the nasal route, via the buildup of positive pressure in the nasopharynx, anteriorly displacing the soft palate and tongue from posterior pharyngeal wall, reducing airway obstruction. Use of the Super-NO 2 VA™ for pre-oxygenation and during induction may reduce the risk for oxygen desaturation in patients with obesity or OSA, as well as patients with other comorbidities that are associated with difficult intubation.…”
Section: Discussionmentioning
confidence: 99%
“…4,5 For these pa-tients and others with confirmed or suspected difficult airways, management alternatives including nasal ventilation may be more appropriate. 3,6,7 The SuperNO 2 VA™ (Vyaire Medical, Mettawa, IL, USA) device is a nasal mask developed to provide nasal positive pressure ventilation in spontaneously breathing and apneic patients during anesthesia and endotracheal intubation (Figure 1). In a pilot study designed to evaluate the clinical performance of the SuperNO 2 VA™ in paralyzed patients under general anesthe-sia, nasal mask ventilation was successfully implemented in 97% of patients with nasal oxygenation continued during laryngoscopy and orotracheal intubation, with no adverse events.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…También para el manejo de angioedema y espasmo glótico (17,18,). El mecanismo de acción en caso de hipoxemia será similar a la CPAP usada para el manejo del Síndrome de Apnea-Hipopnea del sueño donde su eficacia está demostrada y cuenta con gran experiencia clínica tanto en adultos como en población pediátrica: al superar la presión de cierre y de colapso mantiene abierta la laringe y la vía aérea superior; esto a su vez permite la expansión pulmonar y evita la formación de atelectasias, mejorando el intercambio de gas en un pulmón congestivo y además puede reducir la hiperinsuflación dinámica que suele presentarse en casos de hiperreactividad bronquial o distrés (19,20).…”
Section: Superno2va (Vyaire Medical Mettawa Il)unclassified